The impact of borderline personality disorder on residential substance abuse treatment dropout among men

Drug and Alcohol Dependence

Volumn 121, Issue 1-2, 2012, Pages 97-102

  Tull, Matthew T ^a   Gratz, Kim L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Borderline personality disorder; Comorbidity; Personality disorders; Substance abuse treatment; Substance use disorder; Treatment retention

Indexed keywords

ADULT; ARTICLE; BORDERLINE STATE; CONTRACT; HEALTH BEHAVIOR; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RESIDENTIAL CARE; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT WITHDRAWAL;

ADULT; BORDERLINE PERSONALITY DISORDER; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; RESIDENTIAL TREATMENT; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 84855870088     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.08.014     Document Type: Article

References (57)

1. Araujo L., Goldberg P., Eyma J., Madhusoodanan S. The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program. J. Subst. Abuse Treat. 1996, 13:61-66.
2. Ball S.A., Tennen H., Poling J.C., Kranzler H.R., Rounsaville B.J. Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers. J. Abnorm. Psychol. 1997, 106:545-553.
3. Blake D.D., Weathers F.W., Nagy L., Kaloupek D.G., Klauminzer G., Charney D.S., Keane T.M. The Clinician Administered PTSD Scale 1990, National Center for PTSD, Boston, MA.
4. Bornovalova M.A., Daughters S.B. How does dialectical behavior therapy facilitate treatment retention among individuals with comorbid borderline personality disorder and substance use disorders?. Clin. Psychol. Rev. 2007, 27:923-943.
5. Bornovalova M.A., Gratz K.L., Daughters S.B., Nick B., Delany-Brumsey A., Lynch T.R., Kosson D., Lejuez C.W. A multimodal assessment of the relationship between emotion dysregulation and borderline personality disorder among inner-city substance users in residential treatment. J. Psychiatr. Res. 2008, 42:717-726.
6. Brooner R.K., Ing V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment seeking opioid abusers. Arch. Gen. Psychiatry 1997, 54:71-80.
7. Brown P.J., Stout R., Mueller T. Post-traumatic stress disorder and substance abuse relapse among women: a pilot study. Psychol. Addict. Behav. 1996, 10:124-128.
8. Cacciola J.S., Alterman A.I., McKay J.R., Rutherford M.J. Psychiatric comorbidity in patients with substance use disorders: do not forget Axis II disorders. Psychiatr. Ann. 2001, 31:321-331.
9. Cacciola J.S., Rutherford M.J., Alterman A.I., McKay J.R., Snider E.C. Personality disorders and treatment outcome in methadone maintenance patients. J. Nerv. Ment. Dis. 1996, 184:234-239.
10. Darke S., Williamson A., Ross J., Teesson M., Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend. 2004, 74:77-83.
11. Darke S., Ross J., Williamson A., Teesson M. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction 2005, 100:1121-1130.
12. Daughters S.B., Lejuez C.W., Bornovalova M.A., Kahler C.W., Strong D.R., Brown R.A. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. J. Abnorm. Psychol. 2005, 114:729-734.
13. Daughters S.B., Stipelman B.A., Sargeant M.N., Schuster R., Bornovalova M.A., Lejuez C.W. The interactive effects of antisocial personality disorder and court-mandated treatment status on substance abuse treatment dropout. J. Subst. Abuse Treat. 2008, 34:157-164.
14. DeJong C.A., Van den Brink W., Harteveld F.M., Van der Wielen E. Personality disorders in alcoholics and drug addicts. Compr. Psychiatry 1993, 34:87-94.
15. Dingle G.A., King P. Prevalence and impact of co-occurring psychiatric disorders on outcomes from a private hospital drug and alcohol treatment program. Ment. Health Subst. 2009, 2:13-23.
16. Elhai J.D., Gray M.J., Kashdan T.B., Franklin C. Which instruments are most commonly used to assess traumatic event exposure and posttraumatic effects? A survey of traumatic stress professionals. J. Trauma Stress 2005, 18:541-545.
17. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0) 1996, New York State Psychiatric Institute, New York.
18. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
19. Gratz K.L., Rosenthal M., Tull M.T., Lejuez C.W., Gunderson J.G. An experimental investigation of emotion dysregulation in borderline personality disorder. J. Abnorm. Psychol. 2006, 115:850-855.
20. Gratz K.L., Tull M.T., Gunderson J.G. Preliminary data on the relationship between anxiety sensitivity and borderline personality disorder: the role of experiential avoidance. J. Psychiatr. Res. 2008, 42:550-559.
21. Gratz K.L., Tull M.T., Baruch D.E., Bornovalova M.A., Lejuez C.W. Factors associated with co-occurring borderline personality disorder among inner-city substance users: the roles of childhood maltreatment, negative affect intensity/reactivity, and emotion dysregulation. Compr. Psychiatry 2008, 49:603-615.
22. Greenberg W., Otero J., Villanueva L. Irregular discharges from a dual diagnosis unit. Am. J. Drug Alcohol Abuse 1994, 20:355-371.
23. Hättenschwiler J., Rüesch P.P., Modestin J.J. Comparison of four groups of substance-abusing in-patients with different psychiatric comorbidity. Acta Psychiatr. Scand. 2001, 104:59-65.
24. Hernandez-Avila C.A., Burleson J.A., Poling J., Tennen H., Rounsaville B.J., Kranzler H.R. Personality and substance use disorders as predictors of criminality. Compr. Psychiatry 2000, 41:276-283.
25. Johnson D.M., Shea M., Yen S., Battle C.L., Zlotnick C., Sanislow C.A., Grilo C.M., Skodol A.E., Bender D.S., McGlashan T.H., Gunderson J.G., Zanarini M.C. Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders Study. Compr. Psychiatry 2003, 44:284-292.
26. Kessler R.C., Chiu W., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
27. Kokkevi A., Stefanis N., Anastasopoulous E., Kostogianni C. Personality disorders in drug abusers: prevalence and their association with Axis I disorders as predictors of treatment retention. Addict. Behav. 1998, 23:841-853.
28. Kosten T.A., Kosten T.R., Rounsaville B.J. Personality disorders in opiate addicts show prognostic specificity. J. Subst. Abuse Treat. 1989, 6:163-168.
29. Kruedelbach N., McCormick R.A., Schulz S.C., Grueneich R. Impulsivity, coping styles, and triggers for craving in substance abusers with borderline personality disorders. Pers. Disord. 1993, 7:214-222.
30. Lejuez C.W., Zvolensky M.J., Daughters S.B., Bornovalova M.A., Paulson A., Tull M.T., Ettinger K., Otto M.W. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav. Res. Ther. 2008, 46:811-818.
31. Linehan M.M. Cognitive-behavioral Treatment of Borderline Personality Disorder 1993, Guilford Press, New York.
32. Links P.S., Heslegrave R.J., Mitton J.E., Van Reekum R. Borderline personality disorder and substance abuse: consequences of comorbidity. Can. J. Psychiatry 1995, 40:9-14.
33. Maglione M., Chao B., Anglin D. Residential treatment of methamphetamine users: correlates of drop-out from the California Alcohol and Drug Data System (CADDS), 1994-1997. Addict. Res. 2000, 8:65-79.
34. Marlowe D.B., Kirby K.C., Festinger D.S., Husband S.D., Platt J.J. Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. J. Nerv. Ment. Dis. 1997, 185:483-490.
35. Martínez-Raga J., Marshall E., Keaney F., Ball D., Strang J. Unplanned versus planned discharges from in-patient alcohol detoxification: retrospective analysis of 470 first-episode admissions. Alcohol Alcohol. 2002, 37:277-281.
36. Morgenstern J., Langenbucher J., Labouvie E., Miller K.J. The comorbidity of alcoholism and personality disorders in a clinical population: prevalence and relation to alcohol typology variables. J. Abnorm. Psychol. 1997, 106:74-84.
37. Powell G., Peveler R. Nature and prevalence of personality disorders amongst patients receiving treatment for alcohol dependence. J. Ment. Health 1996, 5:305-314.
38. Ravndal E., Vaglum P. The influence of personality disorders on treatment completion in a hierarchical therapeutic community for drug abusers. Eur. Addict. Res. 1995, 1:178-186.
39. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373:2223-2233.
40. Reiger D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990, 264:2511-2518.
41. Ross S., Dermatis H., Levounis P., Galanter M. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. Am. J. Drug Alcohol Abuse 2003, 29:263-279.
42. Sansone R.A., Whitecar P., Wiederman M.W. The prevalence of borderline personality among buprenorphine patients. Int. J. Psychiatry Med. 2008, 38:217-226.
43. Shalev A.Y., Freedman S., Peri T., Brandes D., Sahar T. Predicting PTSD in trauma survivors: prospective evaluation of self-report and clinician-administered instruments. Br. J. Psychiatry 1997, 170:558-564.
44. Simpson D., Joe G.W., Fletcher B.W., Hubbard R.L., Anglin M. A national evaluation of treatment outcomes for cocaine dependence. Arch. Gen. Psychiatry 1999, 56:507-514.
45. Stark M.J. Dropping out of substance abuse treatment: a clinically oriented review. Clin. Psychol. Rev. 1992, 12:93-116.
46. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 1996, Harper Collins, New York. 3rd ed.
47. Tadić A., Wagner S., Hoch J., Başkaya ö., von Cube R., Skaletz C., Lieb K., Dahmen N. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Psychopathology 2009, 42:257-263.
48. Thomas V.H., Melchert T.P., Banken J.A. Substance dependence and personality disorders: comorbidity and treatment outcome in an inpatient treatment population. J. Stud. Alcohol Drugs 1999, 60:271-277.
49. Trull T.J., Sher K.J., Minks-Brown C., Durbin J., Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin. Psychol. Rev. 2000, 20:235-253.
50. Verheul R., van den Brink W., Hartgers C. Prevalence of personality disorders among alcoholics and drug addicts: an overview. Eur. Addict. Res. 1995, 1:166-177.
51. Weathers F.W., Keane T.M., Davidson J.T. Clinician-Administered PTSD Scale: a review of the first ten years of research. Depress. Anxiety 2001, 13:132-156.
52. Weiss R.D., Mirin S.M., Griffin M.L., Gunderson J.G., Hufford C. Personality disorders in cocaine dependence. Compr. Psychiatry 1993, 34:145-149.
53. Wölwer W., Burtscheidt W., Redner C., Schwarz R., Gaebel W. Out-patient behaviour therapy in alcoholism: impact of personality disorders and cognitive impairments. Acta Psychiatr. Scand. 2001, 103:30-37.
54. Zanarini M.C., Skodol A.E., Bender D., Dolan R., Sanislow C., Schaefer E., Morey L., Grilo C.M., Shea M.T., McGlashan T.H., Gunderson J.G. The Collaborative Longitudinal Personality Disorders Study: reliability of Axis I and II diagnoses. J. Pers. Disord. 2000, 14:291-299.
55. Zanarini M.C., Frankenburg F.R., Vujanovic A.A., Hennen J.J., Reich D.B., Silk K.R. Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission. Acta Psychiatr. Scand. 2004, 110:416-420.
56. Zanarini M.C., Frankenburg F.R., Sickel A.E., Young L. The Diagnostic Interview for DSM-IV Personality Disorders (DIPD-IV) 1996, McClean Hospital, Boston, MA.
57. Zikos E., Gill K.J., Charney D.A. Personality disorders among alcoholic outpatients: prevalence and course in treatment. Can. J. Psychiatry 2010, 55:65-73.